| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/07435800.2017.1373662 |
| P698 | PubMed publication ID | 28972408 |
| P2093 | author name string | Yan Wang | |
| Na Wang | |||
| Peng Xue | |||
| Yukun Li | |||
| Jianxia Ma | |||
| Xuelun Wu | |||
| P2860 | cites work | Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes | Q44797704 |
| Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus. | Q44985315 | ||
| Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes | Q46092734 | ||
| Type I collagen gel in seeding medium improves murine mesencymal stem cell loading onto the scaffold, increases their subsequent proliferation, and enhances culture mineralization. | Q46127594 | ||
| Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases | Q47902833 | ||
| Aminoterminal propeptide of type I procollagen (PINP) in chronic kidney disease patients: the assay matters. | Q47909759 | ||
| Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus | Q47914481 | ||
| Bone Structure and Predictors of Fracture in Type 1 and Type 2 Diabetes. | Q47917349 | ||
| Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma. | Q51827129 | ||
| Sclerostin and DKK1 in Primary Hyperparathyroidism | Q58903530 | ||
| Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis | Q24655666 | ||
| Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis | Q28256427 | ||
| Regulation of Wnt/β-catenin signaling within and from osteocytes | Q28286814 | ||
| Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation | Q28505419 | ||
| Bone structure and turnover in type 2 diabetes mellitus | Q33350839 | ||
| Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction | Q33562209 | ||
| The effect of renal dysfunction on circulating sclerostin level in patients with type 2 diabetes | Q33905129 | ||
| Mediation role of C-reactive protein on the association between smoking quantity and type 2 diabetes in current Chinese smokers | Q33930272 | ||
| Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women | Q34262453 | ||
| Relationship of Dickkopf1 (DKK1) with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus | Q34450519 | ||
| Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men | Q34544147 | ||
| Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling | Q35224081 | ||
| Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes | Q35780843 | ||
| DKK1 rescues osteogenic differentiation of mesenchymal stem cells isolated from periodontal ligaments of patients with diabetes mellitus induced periodontitis | Q35960497 | ||
| Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism | Q35983181 | ||
| SOST/sclerostin, an osteocyte-derived negative regulator of bone formation | Q36115718 | ||
| The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. | Q36328511 | ||
| Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice | Q36335493 | ||
| Sclerostin levels during growth in children. | Q36711126 | ||
| Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium | Q36762750 | ||
| Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton | Q36774955 | ||
| How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits. | Q36880655 | ||
| Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women | Q37350836 | ||
| Monoclonal antibodies for the treatment of osteoporosis | Q38068600 | ||
| Diabetes and bone health | Q38102817 | ||
| Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies | Q38174587 | ||
| Sclerostin: recent advances and clinical implications | Q38261694 | ||
| Type 2 diabetes and the skeleton: new insights into sweet bones | Q38586132 | ||
| Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro | Q40307786 | ||
| Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus | Q43739331 | ||
| Hypovitaminosis D and incidence of obesity: a prospective study. | Q43789171 | ||
| P304 | page(s) | 1-10 | |
| P577 | publication date | 2017-10-03 | |
| P1433 | published in | Endocrine Research | Q5376305 |
| P1476 | title | Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients |
| Q64998522 | Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development. |
| Q90388414 | Metformin protects bone mass in ultra-high-molecular-weight polyethylene particle-induced osteolysis by regulating osteocyte secretion |
| Q90303878 | MicroRNA-92a-1-5p influences osteogenic differentiation of MC3T3-E1 cells by regulating β-catenin |
| Q64055454 | Sal B targets TAZ to facilitate osteogenesis and reduce adipogenesis through MEK-ERK pathway |
| Q91964524 | Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study |
| Q58725004 | Skeletal Fragility in Type 2 Diabetes Mellitus |
| Q91662693 | Therapeutic potentials and modulatory mechanisms of fatty acids in bone |
Search more.